7 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders (COSYN)
Date du début: 1 janv. 2016, Date de fin: 31 déc. 2020,
COSYN integrates outstanding European academic and three large Pharma to exploit genomic findings for intellectual disability (ID), autism, and schizophrenia. We capitalise on comorbidity, from clinic to cells and synapses, and have access to large existing samples. We focus on rare genetic variants of strong effect in patients with clinical comorbidity. Our aims are: (1) Understand comorbidity by ...
Voir le projet
14
Participants partenaires
TERMINÉ
Targets and biomarkers for antiepileptogenesis (EPITARGET)
Date du début: 1 nov. 2013, Date de fin: 31 oct. 2018,
Epilepsy is a devastating condition affecting over 50 million people worldwide. This multidisciplinary project is focused on the process leading to epilepsy, epileptogenesis, in adults. Our main hypothesis is that there are combinations of various causes, acting in parallel and/or in succession, that lead to epileptogenesis and development of seizures. Our central premise and vision is that a comb ...
Voir le projet
20
Participants partenaires
TERMINÉ
European Consortium for Communicating Stem Cell Research (EuroStemCell)
Date du début: 1 janv. 2015, Date de fin: 31 mars 2018,
The European Consortium for Communicating Stem Cell Research (EuroStemCell) unites 33 partner institutions, that collectively represent >400 stem cell research groupings across Europe. Our common goal is to provide trusted high quality information on stem cells accessible to citizens and stakeholders across Europe, through support and further development of the multi-lingual European Stem Cell Inf ...
Voir le projet
32
Participants partenaires
TERMINÉ
European stem cell consortium for neural cell replacement, reprogramming and functional brain repair (Neurostemcellrepair)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2017,
...The research plan is constructed on exchange of tools, sharing of protocols and expertise and joint deliverables among the participants. We will address issues related to the control of progenitor proliferation and differentiation into authentic, functional and phenotypically stable dopaminergic or striatal neurons, and exploit new technology for cell reprogramming. We will develop strategies to o ...
Voir le projet
13
Participants partenaires
TERMINÉ
IMAging GEnetics for MENtal Disorders (IMAGEMEND)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2017,
"Mental disorders are leading causes of disability, absence from work and premature retirement in Europe. While magnetic resonance imaging (MRI) facilities are broadly available and a vast research literature exists, few neuroimaging applications have reached clinical practice in psychiatry. A major problem is that mental illnesses are currently diagnosed as discrete entities defined clinically. I ...
Voir le projet
15
Participants partenaires
TERMINÉ
European Consortium for Communicating Stem Cell Research (EuroStemCell)
Date du début: 1 mars 2010, Date de fin: 28 févr. 2015,
The European Consortium for Communicating Stem Cell Research, EUROSTEMCELL, brings together the major current FP6 and FP7 stem cell projects, the European Clinical Research Infrastructure Network, and four internationally recognized European stem cell centres to develop a comprehensive, coordinated platform for collation, dissemination and archiving of information on stem cell biology and regenera ...
Voir le projet
11
Participants partenaires
TERMINÉ
The discovery of future neuro-therapeutic molecules (NEUROSCREEN)
Date du début: 1 août 2008, Date de fin: 31 juil. 2011,
NEUROscreen is an industry-lead project combining novel neural stem cell bioassays & post-genomic chemical genetics to discover potential drugs of relevance to neurological diseases, regenerative medicine & cancer. Small molecule inhibitors of the growth of clonal, human neural cancer stem cells have the prospect of being unique medicines targeting the elusive cancer stem cell. Chemical modulators ...
Voir le projet